Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the ...

Finding offers potential new target for treatmentPsoriasis, a painful and uncomfortable inflammatory skin condition that ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...

CLEVELAND—Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the activity of disease ...

A new study published in the Archives of Dermatological Research found that patients with psoriasis who were receiving ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

A study found patients treated with interleukin inhibitors did not experience a difference in the rates of major adverse ...

psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...